Item 2.02 Results of Operations and Financial Condition.

On August 5, 2021, Oyster Point Pharma, Inc. (the "Company") issued a press release to report the Company's financial results for the quarter ended June 30, 2021. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.



The information in this Item 2.02 and the attached Exhibit 99.1 are being
furnished and shall not be deemed to be "filed" for the purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
otherwise subject to the liabilities of that section, nor shall they be deemed
to be incorporated by reference in any filing made by the Company under the
Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.
Exhibit No.                                        Description
  99.1                             Press Release dated August 5, 2021
104                                Cover Page Interactive Data File

(embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses